Arnold M, Karim-Kos HE, Coebergh JW, Byrnes G, Antilla A, Ferlay J, et al. Recent trends in incidence of five common cancers in 26 European countries since 1988: Analysis of the European Cancer Observatory. Eur J Cancer. 2015;51(9):1164–87.
Baburin A, Aareleid T, Rahu M, Reedik L, Innos K. Recent changes in breast cancer incidence and mortality in Estonia: Transition to the west. Acta Oncol. 2016;55(6):728–33.
Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Nikšić M, et al. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391(10125):1023–75.
Baburin A, Aareleid T, Padrik P, Valvere V, Innos K. Time trends in population-based breast cancer survival in Estonia: Analysis by age and stage. Acta Oncol. 2014;53(2):226–34.
Mägi M, Härmaorg P, Innos K. Cancer in Estonia 2017. Tallinn: National Institute for Health Development; 2020. Available from: https://intra.tai.ee//images/prints/documents/159129026779_Cancer_in_Estonia_2017.pdf [cited 21 Mar 2021].
Danckert B, Ferlay J, Engholm G, Hansen HL, Johannesen TB, Khan S, et al. NORDCAN: Cancer Incidence, Mortality, Prevalence and Survival in the Nordic Countries, Version 8.2 (26.03.2019). Association of the Nordic Cancer Registries. Danish Cancer Society. Available from http://www.ancr.nu [cited 26 Mar 2021].
Office for National Statistics. Cancer survival in England: adult, stage at diagnosis and childhood – patients followed up to 2018. Available from: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/datasets/cancersurvivalratescancersurvivalinenglandadultsdiagnosed [cited 14 May 2021].
Minicozzi P, Van Eycken L, Molinie F, Innos K, Guevara M, Marcos-Gragera R, et al. Comorbidities, age and period of diagnosis influence treatment and outcomes in early breast cancer. Int J Cancer. 2019;144(9):2118–27.
Cardoso F, Kyriakides S, Ohno S, Penault-Llorca F, Poortmans P, Rubio IT, et al. Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2019;30(8):1194–220.
Veronesi U, Alberto L, Vecchio M, Del, Greco M, Galimberti V, Mirella M, et al. Radiotherapy after breast-preserving surgery in women with localized cancer of the breast. N Engl J Med. 1993;328(22):1587–91.
Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, et al. Twenty-Year Follow-Up of a Randomized Trial Comparing Total for the Treatment of Invasive Breast Cancer. N Engl J Med. 2002;347(16):1233–41.
Darby S, McGale P, Correa C, Taylor C, Arriagada R, Clarke M, et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: Meta-analysis of individual patient data for 10 801 women in 17 randomised trials. Lancet. 2011;378(9804):1707–16.
Cardoso F, Senkus E, Costa A, Papadopoulos E, Aapro M, André F, et al. 4th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 4). Ann Oncol. 2018;29(8):1634–57.
Grau C, Defourny N, Malicki J, Dunscombe P, Borras JM, Coffey M, et al. Radiotherapy equipment and departments in the European countries: Final results from the ESTRO-HERO survey. Radiother Oncol. 2014;112(2):155–64.
Sant M, Meneghini E, Bastos J, Rossi PG, Guevara M, Innos K, et al. Endocrine treatment and incidence of relapse in women with oestrogen receptor-positive breast cancer in Europe: a population-based study. Breast Cancer Res Treat. 2020;183(2):439–50.
Estonian Health Insurance Fund. Available from: https://www.haigekassa.ee/en [cited 6 Jan 2021].
Ezendam NPM, Stirbu I, Leinsalu M, Lundberg O, Kalediene R, Wojtyniak B, et al. Educational inequalities in cancer mortality differ greatly between countries around the Baltic Sea. Eur J Cancer. 2008;44(3):454–64.
Gadeyne S, Menvielle G, Kulhanova I, Bopp M, Deboosere P, Eikemo TA, et al. The turn of the gradient? Educational differences in breast cancer mortality in 18 European populations during the 2000s. Int J Cancer. 2017;141(1):33–44.
Leinsalu M, Vågerö D, Kunst AE. Estonia 1989–2000: Enormous increase in mortality differences by education. Int J Epidemiol. 2003;32(6):1081–7.
Innos K, Mägi M, Tekkel M, Aareleid T. Place of residence predicts breast cancer stage at diagnosis in Estonia. Eur J Public Health. 2011;21(3):376–80.
Banerjee M, George J, Yee C, Hryniuk W, Schwartz K. Disentangling the effects of race on breast cancer treatment. Cancer. 2007;110(10):2169–77.
Lin Y, Wimberly MC, Da Rosa P, Hoover J, Athas WF. Geographic access to radiation therapy facilities and disparities of early-stage breast cancer treatment. Geospat Health. 2018;13(1):93–101.
Lautner M, Lin H, Shen Y, Parker C, Kuerer H, Shaitelman S, et al. Disparities in the use of breast-conserving therapy among patients with early-stage breast cancer. JAMA Surg. 2015;150(8):778–86.
Voti L, Richardson LC, Reis IM, Fleming LE, MacKinnon J, Coebergh JWW. Treatment of local breast carcinoma in Florida: The role of the distance to radiation therapy facilities. Cancer. 2006;106(1):201–7.
Liu Y, Zhang J, Huang R, Feng W-L, Kong Y-N, Xu F, et al. Influence of occupation and education level on breast cancer stage at diagnosis, and treatment options in China: A nationwide, multicenter 10-year epidemiological study. Medicine. 2017;96(15):e6641.
Wheeler SB, Kuo TM, Durham D, Frizzelle B, Reeder-Hayes K, Meyer AM. Effects of distance to care and rural or urban residence on receipt of radiation therapy among North Carolina Medicare enrollees with breast cancer. N C Med J. 2014;75(4):239–46.
Seneviratne S, Campbell I, Scott N, Lawrenson R. A cohort study of ethnic differences in use of adjuvant chemotherapy and radiation therapy for breast cancer in New Zealand. BMC Health Serv Res. 2017;17(1):1–10.
Parekh A, Fu W, Hu C, Shen CJ, Alcorn S, Rao AD, et al. Impact of race, ethnicity, and socioeconomic factors on receipt of radiation after breast conservation surgery: analysis of the national cancer database. Breast Cancer Res Treat. 2018;172(1):201–8.
Liu E, Santibáñez P, Puterman ML, Weber L, Ma X, Sauré A, et al. A Quantitative Analysis of the Relationship between Radiation Therapy Use and Travel Time. Int J Radiat Oncol Biol Phys. 2015;93(3):710–8.
Baldwin LM, Patel S, Andrilla CHA, Rosenblatt RA, Doescher MP. Receipt of recommended radiation therapy among rural and urban cancer patients. Cancer. 2012;118(20):5100–9.
Athas WF, Adams-Cameron M, Hunt WC, Amir-Fazli A, Key CR. Travel distance to radiation therapy and receipt of radiotherapy following breast-conserving surgery. J Natl Cancer Inst. 2000;92(3):269–71.
Dragun AE, Huang B, Tucker TC, Spanos WJ. Disparities in the application of adjuvant radiotherapy after breast-conserving surgery for early stage breast cancer. Cancer. 2011;117(12):2590–8.
Allemani C, Storm H, Voogd AC, Holli K, Izarzugaza II, Torrella-Ramos A, et al. Variation in “standard care” for breast cancer across Europe: A EUROCARE-3 high resolution study. Eur J Cancer. 2010;46(9):1528–36.
Hiatt RA, Breen N. The Social Determinants of Cancer. A Challenge for Transdisciplinary Science. Am J Prev Med. 2008;35(2S):141–50.
Ojamaa K, Veerus P, Baburin A, Everaus H, Innos K. Increasing incidence and survival of corpus uteri cancer in Estonia over the past two decades. Cancer Epidemiol. 2019;62:101566.
Mallin K, Palis BE, Watroba N, Stewart AK, Walczak D, Singer J, et al. Completeness of American cancer registry treatment data: Implications for quality of care research. J Am Coll Surg. 2013;216(3):428–37.
Malin JL, Kahn KL, Adams J, Kwan L, Laouri M, Ganz PA. Validity of cancer registry data for measuring the quality of breast cancer care. J Natl Cancer Inst. 2002;94(11):835–44.
StataCorp. Stata Statistical Software Release 16. College Station. TX: StataCorp LLC; 2019.
Cummings P. Methods for estimating adjusted risk ratios. Stata J. 2009;9(2):175–96.
NCDB Public Benchmark Reports. Available from: http://oliver.facs.org/BMPub/index.cfm [cited 20 Mar 2021].
Cancer Research UK. Available from: https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/breast-cancer/diagnosis-and-treatment#heading-Two [cited 20 Mar 2021].
Estonian Cancer Control Plan 2021–2030 [Vähitõrje tegevuskava 2021–2030]. Tallinn: Sotsiaalministeerium, Tervise Arengu Instituut; 2021. Available from: https://www.sm.ee/sites/default/files/content-editors/Tervishoid/Vahiravi/vahitorje_tegevuskava_2021-2030.pdf.
Smith BD, Gross CP, Smith GL, Galusha DH, Bekelman JE, Haffty BG. Effectiveness of radiation therapy for older women with early breast cancer. J Natl Cancer Inst. 2006;98(10):681–90.
Hughes KS, Schnaper LA, Bellon JR, Cirrincione CT, Berry DA, McCormick B, et al. Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: Long-term follow-up of CALGB 9343. J Clin Oncol. 2013;31(19):2382–7.
Metcalfe K, Lynch HT, Ghadirian P, Tung N, Olivotto I, Warner E, et al. Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. J Clin Oncol. 2004;22(12):2328–35.
Estonian HDevelopmentR. 2019/2020. Available from: https://inimareng.ee/en/changes-in-land-use-distortion-of-the-meaning-of-urban-and-rural.html [cited 15 Mar 2021].
Rydland HT, Fjær EL, Eikemo TA, Huijts T, Bambra C, Wendt C, et al. Educational inequalities in mortality amenable to healthcare. A comparison of European healthcare systems. PLoS One. 2020;15(7):1–17.
Shavers VL, Brown ML. Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst. 2002;94(5):334–57.
Ballard-Barbash R, Potosky AL, Harlan LC, Nayfield SG, Kessler LG. Factors associated with surgical and radiation therapy for early stage breast cancer in older women. J Natl Cancer Inst. 1996;88(11):716–26.
Aarts MJ, Hamelinck VC, Bastiaannet E, Coebergh JWW, Liefers GJ, Voogd AC, et al. Small but significant socioeconomic inequalities in axillary staging and treatment of breast cancer in the Netherlands. Br J Cancer. 2012;107(1):12–7.
Michalski TA, Nattinger AB. The influence of black race and socioeconomic status on the use of breast-conserving surgery for Medicare beneficiaries. Cancer. 1997;79(2):314–9.
Smith GL, Xu Y, Shih YCT, Giordano SH, Smith BD, Hunt KK, et al. Breast-Conserving Surgery in Older Patients with Invasive Breast Cancer: Current Patterns of Treatment Across the United States. J Am Coll Surg. 2009;209(4):425–33.
Hershman DL, Buono D, McBride RB, Tsai WY, Joseph KA, Grann VR, et al. Surgeon characteristics and receipt of adjuvant radiotherapy in women with breast cancer. J Natl Cancer Inst. 2008;100(3):199–206.
Kravdal Ø. Social inequalities in cancer survival. Popul Stud (NY). 2000;54(1):1–18.
Meng L, Maskarinec G, Wilkens L. Ethnic differences and factors related to breast cancer survival in Hawaii. Int J Epidemiol. 1997;26(6):1151–8.
Polednak AP. Survival of breast cancer patients in Connecticut in relation to socioeconomic and health care access indicators. J Urban Heal. 2002;79(2):211–8.
Osborne C, Ostir GV, Du X, Peek MK. The influence of marital status on the stage at diagnosis, treatment, and survival of older women with breast cancer. Breast Cancer Res Treat. 2005;93:41–7.
Parikh DA, Chudasama R, Agarwal A, Rand A, Qureshi MM, Ngo T, et al. Race/Ethnicity, Primary Language, and Income Are Not Demographic Drivers of Mortality in Breast Cancer Patients at a Diverse Safety Net Academic Medical Center. Int J Breast Cancer. 2015;2015:1–6.
Rendall MS, Weden MM, Favreault MM, Waldron H. The Protective Effect of Marriage for Survival: A Review and Update. Demography. 2011;48(2):481–506.
Silliman R, Troyan SL, Guadagnoli E, Ph D, Kaplan SH, Ph D, et al. The Impact of Age, Marital Status, and Physician- Patient Interactions on the Care of Older Women with Breast Carcinoma. Cancer. 1997;80(7):1326–34.
Goodwin JS, Satish S, Anderson ET, Nattinger AB, Freeman JL. Effect of nurse case management on the treatment of older women with breast cancer. J Am Geriatr Soc. 2003;51(9):1252–9.